IDH1 and central nervous system cancer: In this study, IDH1 gene mutation was detected in 86 cases (74.8%), IDH2 gene mutation in five cases (4.4%) and TERT promoter mutation in 68 cases (59.1%), the results showed that IDH1/2 and TERT genes were related factors affecting the prognosis of patients with glioma.